Universitat de València
Valencia, 46010, Spain
NCT Number: NCT03995095
This work aims to study the benefits that the therapeutic interview Kibo in palliative care patients can have for spirituality.
A parallel randomized controlled trial of two groups was performed. Information was collected on 60 palliative care patients during the moments before and after the intervention.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Valencia, 46010, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a) Estimated time of survival: Patients with a life expectancy of two weeks or less will not be intervened.
The kibo protocol is a therapeutic interview designed to address the spiritual needs of patients at the end of life.
Time frame: Baseline up to 4 weeks
This variable was assessed with the Spirituality questionnaire from the Spanish Society of Palliative Care (SECPAL). This questionnaire contains 8 items, and it provides scores from 0 to 32, where higher values represent a better outcome.
In order to observe the change in the dimension of spirituality, it was measured at in two time points:
First measurement: PRE. Once the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: POST. Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Between first and second measurement, the control group received the usual psychological attention, whereas the intervention group received usual psychological attention plus attention of spiritual needs following the Kibo protocol (intervention).
Time frame: Baseline up to 4 weeks
This variable was assessed with the Brief Resilient Coping Scale (BRCS). This scale contains 4 items, and it provides scores from 4 to 20, where higher values represent a better outcome.
In order to observe the change in the dimension of resilience, it was measured at in two time points:
First measurement: PRE. Once the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: POST. Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Between first and second measurement, the control group received the usual psychological attention, whereas the intervention group received usual psychological attention plus attention of spiritual needs following the Kibo protocol (intervention).
Time frame: Baseline up to 4 weeks
This variable was assessed with the Short Demoralization Scale (SDS). This scale contains 5 items, and it provides scores from 0 to 20, where lower values represent a better outcome.
In order to observe the change in the dimension of demoralization, it was measured at in two time points:
First measurement: PRE. Once the participant had signed the informed consent, the initial score for this outcome was assessed.
Second measurement: POST. Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out.
Between first and second measurement, the control group received the usual psychological attention, whereas the intervention group received usual psychological attention plus attention of spiritual needs following the Kibo protocol (intervention).
University of Valencia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07181629
Behavior, Behavioral Symptoms
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT07702682
Behavior, Behavioral Symptoms
Elâzığ, Turkey (Türkiye)
View Trial DetailsNCT07505706
Behavior, End of Life Care
Pontoise, France
View Trial DetailsNCT07109050
Palliative Care, Virtual Reality
Lincoln, United Kingdom
View Trial Details